<?xml version="1.0" encoding="UTF-8"?>
<p id="Par140">In another study, Luna et al. [
 <xref ref-type="bibr" rid="CR78">78</xref>] developed a nonfluorescent oligonucleotide array for diagnosis of the entire SARS-CoV genus. The advantage of this microarray was its low costs and high sensitivity when compared to real-time RT-PCR.
</p>
